Michael Scolaro

Michael Scolaro

Sep 16, 2017

Group 6 Copy 183
3
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can regional limb perfusion improve treatment outcomes for birds with distal limb infections?

Distal limb infections are a common problem in birds in wildlife rehabilitation settings. Such infections...

Open Insulin

A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

Can personalized medicine subtype bladder cancer?

Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...

Backer Badge Funded